Published in Biochim Biophys Acta on July 11, 1975
Effects of human alpha-foetoprotein on human B and T lymphocyte proliferation in vitro. Clin Exp Immunol (1978) 1.05
The purification of human enterokinase by affinity chromatography and immunoadsorption. Some observations on its molecular characteristics and comparisons with the pig enzyme. Biochem J (1976) 1.04
Immunofluorescent localisation of enterokinase in human small intestine. Gut (1977) 0.92
Detection, purification and characterization of a human cancer-associated galactosyltransferase acceptor. Biochem J (1979) 0.91
Inhibition of growth of transformed cells and tumors by an endogenous acceptor of galactosyltransferase. Proc Natl Acad Sci U S A (1978) 0.79
Antibody-dependent cellular cytotoxicity to human colon-tumour cells. II. Analysis of the antigens involved. Br J Cancer (1979) 0.78
Two-year follow-up study of patients with known serum concentrations of carcinoembryonic antigen. Can Med Assoc J (1977) 0.75
Fetal antigens on the surface of human lymphoid cells. J Exp Med (1976) 0.75
Specific carcinoembryonic antigens of the human digestive system. J Exp Med (1965) 9.96
The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system. Proc Natl Acad Sci U S A (1969) 6.09
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol (1996) 5.09
Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell (1989) 3.81
Physicochemical studies of the carcinoembryonic antigens of the human digestive system. J Exp Med (1968) 3.08
A population-based study of the usefulness of screening for neuroblastoma. Lancet (1997) 2.92
Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites. Genomics (1994) 2.80
Cellular location of carcinoembryonic antigens of the human digestive system. Cancer Res (1968) 2.68
Interaction forces between red cells agglutinated by antibody. II. Measurement of hydrodynamic force of breakup. Biophys J (1986) 2.43
Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res (1999) 2.25
Bone mineral density in women with depression. N Engl J Med (1996) 2.03
Isolation and characterization of full-length functional cDNA clones for human carcinoembryonic antigen. Mol Cell Biol (1987) 1.99
In loco parentis. Minimal risk as an ethical threshold for research upon children. Hastings Cent Rep (1993) 1.81
Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab (1998) 1.80
Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol (1999) 1.70
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia (2003) 1.64
ADR1-mediated regulation of ADH2 requires an inverted repeat sequence. Mol Cell Biol (1986) 1.57
Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthop Relat Res (1991) 1.56
Immunologic dysfunction in patients with classic hemophilia receiving lyophilized factor VIII concentrates and cryoprecipitate. Can Med Assoc J (1983) 1.52
HLA-D associated alloantisera react with molecules similar to Ia antigens. Proc Natl Acad Sci U S A (1977) 1.52
Association of HTLV-III antibodies and cellular immune status of hemophiliacs. N Engl J Med (1984) 1.51
Monitoring clinical research: an obligation unfulfilled. CMAJ (1995) 1.49
The preparation of purified carcinoembryonic antigen of the human digestive system from large quantities of tumor tissue. Immunochemistry (1972) 1.48
Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study. J Clin Oncol (1993) 1.45
Prognostic features of Ewing sarcoma on plain radiograph and computed tomography scan after initial treatment. A Pediatric Oncology Group study (8346) Cancer (1993) 1.44
Absence of carcinoembryonic antigen-like material in mesothelioma: an immunohistochemical differentiation from other lung cancers. Cancer (1979) 1.43
Interferon alpha-2a and 13-cis-retinoic acid in patients with metastatic renal cell cancer. Cancer Invest (2000) 1.39
Discussion paper: cross-reactivity of primate immunoglobulins. Ann N Y Acad Sci (1969) 1.38
Fluoroquinolone antibiotics: tied to tendon ruptures. Nursing (1996) 1.38
Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol (1993) 1.36
Invasion of selectively permeable sea urchin embryo basement membranes by metastatic tumor cells, but not by their normal counterparts. Cancer Res (1995) 1.35
Biliary glycoprotein, a member of the immunoglobulin supergene family, functions in vitro as a Ca2(+)-dependent intercellular adhesion molecule. Cell Growth Differ (1990) 1.34
Radiotechnetium polyphosphate joint imaging. J Nucl Med (1974) 1.32
beta 2-microglogulin levels in cancerous and other disease states. Clin Chim Acta (1976) 1.29
Skin-reactive soluble antigen from intestinal cancer-cell-membranes and relationship to carcinoembryonic antigens. Lancet (1970) 1.27
Homophilic adhesion between Ig superfamily carcinoembryonic antigen molecules involves double reciprocal bonds. J Cell Biol (1993) 1.26
Vasopressin 1a receptor knockout mice have a subtle olfactory deficit but normal aggression. Genes Brain Behav (2006) 1.25
A population-based study of neuroblastoma incidence, survival, and mortality in North America. J Clin Oncol (1992) 1.20
Vascular involvement in relapsing polychondritis. Can Med Assoc J (1977) 1.20
Purification and characterization of carcinoembryonic antigens of the human digestive system. Nature (1967) 1.20
Evolution of a recombinant (gucoamylase-producing) strain of Fusarium venenatum A3/5 in chemostat culture. Biotechnol Bioeng (2001) 1.17
Position of the carcinoembryonic antigen of the human digestive system in ultrastructure of tumor cell surface. J Natl Cancer Inst (1970) 1.16
Interaction between prognostic factors and treatment. Control Clin Trials (1983) 1.14
Response of lymphocytes from patients with gastrointestinal cancer to the carcinoembryonic antigen of the human digestive system. Cancer (1971) 1.11
Antigenic reversion in human cancer. Annu Rev Med (1971) 1.10
Immune dysfunction in diabetes-prone BB rats. Interleukin 2 production and other mitogen-induced responses are suppressed by activated macrophages. J Exp Med (1984) 1.10
A mouse analogue of the human carcinoembryonic antigen. Cancer Res (1989) 1.10
Studies on a unique diagnostic serum globulin in papular mucinosis (lichen myxedematosus). Clin Exp Immunol (1967) 1.10
Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study. J Clin Oncol (1992) 1.09
Studies on the control of gene expression of the carcinoembryonic antigen family in human tissue. Cancer Res (1989) 1.08
Effects of vasopressin on human memory functions. Science (1981) 1.07
Double-blind trial comparing flunisolide and placebo for the treatment of perennial rhinitis. Clin Allergy (1978) 1.07
Influence of preassay and sequence variations on viral load determination by a multiplex real-time reverse transcriptase-polymerase chain reaction for feline immunodeficiency virus. J Acquir Immune Defic Syndr (2001) 1.07
Lithium-induced thyrotoxicosis. Am J Psychiatry (1979) 1.06
New perspectives in allergic asthma. Can Med Assoc J (1976) 1.06
Demarcating research and treatment: a systematic approach for the analysis of the ethics of clinical research. Clin Res (1992) 1.06
Preparation and isolation of immunologically active glycopeptides from carcinoembryonic antigen (CEA). Int J Cancer (1974) 1.03
Metabolism of human carcinoembryonic antigen in xenogeneic animals. Cancer Res (1973) 1.03
Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia. Blood (1995) 1.03
Primary liquid intake and urinary stone disease. J Chronic Dis (1985) 1.03
Medical grand rounds: alive and well and living in Canada. CMAJ (1990) 1.02
Hypogammaglobulinemia, thymoma and ulcerative colitis. Can Med Assoc J (1967) 1.02
Separation of skin reactive intestinal cancer antigen from the carcinoembryonic antigen of Gold. Science (1972) 1.02
Immunohistopathologic study on carcinoembryonic antigen (CEA)-like material and immunoglobulin A in gastric malignancies. Cancer (1979) 1.02
Evaluation of gut bacterial populations using an electronic e-nose and field asymmetric ion mobility spectrometry: further insights into 'fermentonomics'. J Med Eng Technol (2012) 1.01
The effect of the sequence of erythrocyte sensitization on the bis-diazotized benzidine hemagglutination reaction. J Allergy (1966) 1.01
Polygenic nature of spontaneous diabetes in the rat. Permissive MHC haplotype and presence of the lymphopenic trait of the BB rat are not sufficient to produce susceptibility. Diabetes (1992) 1.01
Proceedings: Intermolecular heterogeneity of the carcinoembryonic antigen. Cancer Res (1974) 1.00
Immunologically active heterosaccharides of carcinoembryonic antigen of human digestive system. Nat New Biol (1972) 1.00
Kohlschütter-Tönz syndrome: epilepsy, dementia, and amelogenesis imperfecta. Am J Med Genet (1993) 0.99
Human carcinoembryonic antigen, an intercellular adhesion molecule, blocks fusion and differentiation of rat myoblasts. J Cell Biol (1993) 0.99
Ability of anti-brain heteroantisera to distinguish thymus-derived lymphocytes in various species. Clin Immunol Immunopathol (1974) 0.99
Oncofetal antigens. Increasing the specificity of the CEA radioimmunoassay. Am J Clin Pathol (1977) 0.99